Zhirui Zhou

机构：Fudan University, Third Affiliated Hospital of Southern Medical University, National Institute of Neurological Disorders and Stroke, National Center for Spinal Disorders, National Clinical Research, Huashan Hospital · ORCID：0000-0001-6877-0376

发表论文 114 篇 · 总被引 2406 次 · h-index 29

代表论文

• Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map (2023 · BMC Cancer · 被引 83)
• Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis (2023 · Journal of Neurology · 被引 22)
• Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive l-[methyl-11C] methionine cohort study with two PET scanners (2023 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 19)
• Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple‐Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1‐Regulated Cholesterol Metabolism (2024 · Advanced Science · 被引 14)
• Deep learning-driven modality imputation and subregion segmentation to enhance high-grade glioma grading (2025 · BMC Medical Informatics and Decision Making · 被引 5)
• An Analysis for IDH ‐Mutant Grade 4 Astrocytoma Based on WHO CNS 5: Implication of Clinical Practice (2025 · Annals of Clinical and Translational Neurology · 被引 5)